Skip to main content
VCbacked
Log inGet Started

Myosana Therapeutics

Seattle, United States

Myosana Therapeutics is a new biotech company developing novel platform technology for non-viral gene delivery.

$5.0M raised
Dec 2022
Seed
BiotechnologyTherapeutics

Top Investors

Muscular Dystrophy AssociationCureDuchenne VenturesJohn BallantyneParent Project Muscular Dystrophy

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Myosana Therapeutics

How much funding has Myosana Therapeutics raised?
Myosana Therapeutics has raised $5.0M in total funding. The most recent round was Seed. The last funding was announced in December 2022.
Who are Myosana Therapeutics's investors?
Myosana Therapeutics's investors include Muscular Dystrophy Association, CureDuchenne Ventures, John Ballantyne, Parent Project Muscular Dystrophy.
Where is Myosana Therapeutics headquartered?
Myosana Therapeutics is headquartered in Seattle, United States.
What does Myosana Therapeutics do?
Myosana Therapeutics is a new biotech company developing novel platform technology for non-viral gene delivery.
What stage is Myosana Therapeutics at?
Myosana Therapeutics is at the Seed stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Myosana Therapeutics — Funding & Investors." VCBacked, December 7, 2022, https://www.vcbacked.co/company/myosana-therapeutics. Accessed July 3, 2026.
APA
VCBacked. (2022). Myosana Therapeutics — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/myosana-therapeutics
Wikipedia (cite web)
{{cite web |title=Myosana Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/myosana-therapeutics |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Allterum Therapeutics
Houston$1.0M
AlpalifeBio
Woburn$9.8M
Renaissance BioScience
Vancouver$599K
Rapport Therapeutics
Boston$250.0M
Epsilogen
London$16.3M
Advanced Microbiome Interventions
Amsterdam$300K